cagrilintide tre GLP-3 Research Peptide | Triple Incretin Amylin Blend Cagrilintide 10mg - Peptas

Ekdahl CT, Kokaia Z, Lindvall O

Early and smaller studies suggested effects on fat metabolism and body fat distribution, but larger obesity trials did not show a robust, clinically meaningful weight loss outcome on their own

Bullous dermatitis herpetiformis

The FDA added it to injectable semaglutide in January 2025, and it climbs the dose axis like everything else. Burning or tingling skin tracks the dose, not the weight lost, and an active-comparator study put the risk about twice that of another weight-loss drug. The mechanism is unsettled: the tempting "it is the drugs signaling arm" story is ruled out, because the strongest GLP-1 signaler in the class carries no such signal